Meghalaya’s EKH ranks highest in Oesophageal cancer linked to Tobacco Use
![](https://www.syllad.com/wp-content/uploads/2024/09/PM-Vishwakarma-724x1024.avif)
In a first-of-its-kind initiative, the Meghalaya Cancer Conclave 2024 brought together a diverse array of professionals including oncologists, researchers, scholars, NGOs, industry leaders, government officials and media representatives. Organized by the Meghalaya Government in partnership with the Apollo Telemedicine Networking Foundation (ATNF), facilitated by the Meghalaya State Cancer Society.
The two day event commenced on February 12 in Shillong under the theme “Closing the Care Gap.” The conclave will conclude on February 13.
Amidst a pressing need for action, the spotlight falls on the cancer scenario in Meghalaya, by recent statistics. According to the Indian Council of Medical Research – National Centre for Disease Informatics and Research (ICMR-NCDIR), the profile of cancer and related health indicators in the North-East Region – 2021 reveals concerning figures. East Khasi Hills District of Meghalaya records the highest rate of Tobacco Related Cancer Reported in India, with 70.4% in males and 46.5% in females.
It was also learnt that in Meghalaya, leading anatomical sites of cancer show significant correlations with tobacco use. Oesophagus ranks highest, representing 66.9% of male cases and 43.1% of female cases. Following closely are hypopharynx and stomach in males, while cervix-uteri and mouth are prominent in females. Nearly two-thirds of male cancers and over 40% of female cancers are attributed to tobacco use, with oesophageal cancer being the most prevalent. These statistics underscore the urgent need for targeted interventions to reduce tobacco consumption and improve cancer prevention efforts, particularly in high-risk populations.
Chaired by Dr. Mazel Ampareen Lyngdoh, Meghalaya’s Minister in charge of Health and Family Welfare, the conclave commenced at Courtyard Marriott Shillong. Dr Ampareen emphasized the importance of collective action and tangible steps to combat cancer, highlighting the crucial role of governmental involvement in patient care and the imperative of prevention strategies. She also addressed the mental health impact of cancer on patients and families, advocating for measures to bridge the care gap and instill a sense of security.
Dr. Anisha Mawlong, Head of Radiation Oncology at Civil Hospital Shillong, shared significant data regarding cancer screening efforts in the region. She revealed that out of 1093 patients screened, 15 were confirmed cases, with 71 suspected cases identified. Notably, in April last, 153 males and 146 females underwent screening, resulting in the detection of 74 confirmed cancer cases. Moreover, Dr. Mawlong announced plans for the establishment of a Cancer Wing at Tura Hospital in Garo Hills, aimed at extending specialized care to the population in that region.
Meanwhile, Dr. L.E. Lyngdoh Nongbri, the State Nodal Officer of the National Tobacco Control Programme (NTCP), shed light on the alarming prevalence of tobacco usage in Meghalaya. Dr. Nongbri revealed that a staggering 47% of adults aged 15 and above are tobacco consumers, with an additional 34% of children aged 13-15 also indulging in tobacco use. The grim reality of 8,000 annual deaths attributable to tobacco-related illnesses underscores the urgent need for intervention to curb this epidemic.
Moreover, as part of the Meghalaya Mission Cancer Prevention & Early Detection initiative, mobile endoscopy units were distributed to various hospitals. Certificates were presented to the following healthcare facilities: Civil Hospital Shillong, Civil Hospital Nongstoin, Jowai West Jaintia Hills, Mawkyrwat South West Khasi Hills, Tirot Singh Memorial, Civil Hospital Baghmara, a civil representative from Williamnagar, Hospital Ampati, Tura, Khliehriat, Ri Bhoi Nongpoh, and Resubelpara. This initiative aims to bolster early detection efforts and improve access to screening services across the region, thereby enhancing outcomes for individuals at risk of developing cancer.
Leave a Reply